<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00771797</url>
  </required_header>
  <id_info>
    <org_study_id>PAOD Study</org_study_id>
    <nct_id>NCT00771797</nct_id>
  </id_info>
  <brief_title>Peripheral Artery Occlusive Diseases (PAOD) Study - Clinical Assessment</brief_title>
  <official_title>Clinical Study to Assess the Clinical Efficacy of Flavanol-rich Cocoa on Vascular Function in Diabetic Patients With PAOD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the clinical efficacy and to simultaneously explore the underlying molecular
      mechanisms of the beneficial effects of flavanol-rich cocoa on vascular function diabetic
      patients with peripheral artery occlusive diseases (PAOD) of the lower extremities will be
      investigated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      50 Type 2 diabetics according to the criteria of the American Diabetes Association suffering
      from PAOD with a pain free walking distance less than 200 m will be enrolled. In a randomized
      controlled parallel group study the before established novel 5-level approach of vascular
      diagnostics will be realised. In order to test the hypothesis, whether cocoa rich in
      flavanols improves vascular function of diabetic PAOD subjects will regularly intake flavanol
      rich cocoa (group 1: 975 mg/d, n=50 versus group 2: 90 mg/d, n=50) over a period of two
      months. Clinical endpoints are the Ankle-Brachial-Index, measured by Doppler ultrasound and
      the pain-free walking distance determined by a treadmill ergometer. All parameters of
      vascular diagnostic (see 5-level approach above) will be determined before and two month
      after cocoa ingestion.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    investigator took study to university hospital duesseldorf
  </why_stopped>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">December 2009</completion_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vascular function</measure>
    <time_frame>before treatment and after 30 and 60 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain free walking distance</measure>
    <time_frame>before treatment and 30 and 60 days afterwards</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Peripheral Artery Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatement with low dose flavanoids over 60 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment with high dose flavanoids over 60 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>high dose flavanoids</intervention_name>
    <description>flavanoid rich cocoa 2 times daily over 60 days</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>low dose flavanoids</intervention_name>
    <description>treatment with flavanoid-low cocoa two times daily over 60 days</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diabetes mellitus type 2 defined by the criteria of the American Diabetes Association

               -  Fasted plasma glucose greater than 126 mg/dL

               -  Plasma glucose levels greater than 200 mg/dL 2 hours after OGT

               -  Casual plasma glucose greater than 200 mg/dL combined with diabetic symptoms.

          2. Endothelial dysfunction defined by FMD &lt;4%

          3. No changes of medication for 2 months

          4. Significant PAOD (level IIb, III)

        Exclusion Criteria:

          1. Ejection fraction &lt;30%

          2. Malignoms

          3. Terminal renal failure with hemodialysis

          4. Relevant cardiac arrhythmias

          5. Acute inflammation defined as CRP &gt;0,5 mg/dl

          6. PAOD (level IV)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tienush Rassaf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinic for Cardiology, University D端sseldorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heinrich-Heine-University, D端sseldorf</name>
      <address>
        <city>D端sseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2008</study_first_submitted>
  <study_first_submitted_qc>October 10, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2008</study_first_posted>
  <last_update_submitted>September 22, 2015</last_update_submitted>
  <last_update_submitted_qc>September 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2015</last_update_posted>
  <responsible_party>
    <name_title>Heinrich-Heine-University D端sseldorf</name_title>
    <organization>Clinic for Cardiology</organization>
  </responsible_party>
  <keyword>PAOD</keyword>
  <keyword>diabetis</keyword>
  <keyword>vascular function</keyword>
  <keyword>in diabetics with PAOD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

